In this section

Timing of statistical benefit of mineralocorticoid receptor antagonists among patients with heart failure and post-myocardial infarction

Bedrouni, W. et al. (2022) Timing of statistical benefit of mineralocorticoid receptor antagonists among patients with heart failure and post-myocardial infarction. Circulation: Heart Failure, 15(10), pp. 988-990. (doi: 10.1161/CIRCHEARTFAILURE.121.009295) (PMID:35924555)

[img] Text
277159.pdf - Accepted Version
222kB

Abstract

No abstract available.

Item Type:Articles
Keywords:Myocardial infarction, spironolactone, eplerenone, morbidity, prognosis.
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Ferreira, Mr Joao Pedro and McMurray, Professor John
Authors: Bedrouni, W., Sharma, A., Pitt, B., Lam, C. S.P., Ni, J., Ferreira, J. P., McMurray, J., Giannetti, N., Girerd, N., Rossignol, P., Solomon, S. D., Claggett, B., Pocock, S., Huynh, T., and Zannad, F.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
Journal Name:Circulation: Heart Failure
Publisher:American Heart Association
ISSN:1941-3289
ISSN (Online):1941-3297
Published Online:04 August 2022
Copyright Holders:Copyright © 2022 American Heart Association, Inc.
First Published:First published in Circulation: Heart Failure 15(10): 988-990
Publisher Policy:Reproduced in accordance with the publisher copyright policy

University Staff: Request a correction | Enlighten Editors: Update this record

Deposit and Record Details